Works by Cuthbertson, Daniel J

Results: 93
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all‐cause mortality in adults, compared with bisphosphonates: An analysis of real‐world, cohort data, with a systematic review and meta‐analysis

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3673, doi. 10.1111/dom.15708
    By:
    • Henney, Alex E.;
    • Riley, David R.;
    • O'Connor, Ben;
    • Hydes, Theresa J.;
    • Anson, Matthew;
    • Zhao, Sizheng Steven;
    • Alam, Uazman;
    • Cuthbertson, Daniel J.
    Publication type:
    Article
    11

    Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2606, doi. 10.1111/dom.15576
    By:
    • Anson, Matthew;
    • Henney, Alex E.;
    • Zhao, Sizheng S.;
    • Ibarburu, Gema H.;
    • Lip, Gregory Y. H.;
    • Cuthbertson, Daniel J.;
    • Nabrdalik, Katarzyna;
    • Alam, Uazman
    Publication type:
    Article
    12

    No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE)

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3621, doi. 10.1111/dom.15257
    By:
    • Rajeev, Surya Panicker;
    • Roberts, Carl Alexander;
    • Brown, Emily;
    • Sprung, Victoria S.;
    • Harrold, Jo A.;
    • Halford, Jason C. G.;
    • Stancak, Andrej;
    • Boyland, Emma J.;
    • Kemp, Graham J.;
    • Perry, Julie;
    • Howarth, Elaine;
    • Jackson, Richard;
    • Wiemken, Andrew;
    • Schwab, Richard;
    • Cuthbertson, Daniel J.;
    • Wilding, John P. H.
    Publication type:
    Article
    13

    All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2897, doi. 10.1111/dom.15185
    By:
    • Riley, David R.;
    • Essa, Hani;
    • Austin, Philip;
    • Preston, Frank;
    • Kargbo, Isatu;
    • Ibarburu, Gema Hernández;
    • Ghuman, Ramandeep;
    • Cuthbertson, Daniel J.;
    • Lip, Gregory Y. H.;
    • Alam, Uazman
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277936
    By:
    • van der Feltz-Cornelis, Christina M.;
    • Sweetman, Jennifer;
    • Allsopp, Gail;
    • Attree, Emily;
    • Crooks, Michael G.;
    • Cuthbertson, Daniel J.;
    • Forshaw, Denise;
    • Gabbay, Mark;
    • Green, Angela;
    • Heightman, Melissa;
    • Hillman, Toby;
    • Hishmeh, Lyth;
    • Khunti, Kamlesh;
    • Lip, Gregory Y. H.;
    • Lorgelly, Paula;
    • Montgomery, Hugh;
    • Strain, W. David;
    • Wall, Emma;
    • Watkins, Caroline;
    • Williams, Nefyn
    Publication type:
    Article
    22

    Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.

    Published in:
    Clinical Science, 2016, v. 130, n. 2, p. 93, doi. 10.1042/CS20150447
    By:
    • Cuthbertson, Daniel J.;
    • Shojaee-Moradie, Fariba;
    • Sprung, Victoria S.;
    • Jones, Helen;
    • Pugh, Christopher J. A.;
    • Richardson, Paul;
    • Kemp, Graham J.;
    • Barrett, Mark;
    • Jackson, Nicola C.;
    • Thomas, E. Louise;
    • Bell, Jimmy D.;
    • Umpleby, A. Margot
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 12, p. 2817, doi. 10.1111/jgh.16727
    By:
    • Henry‐Blake, Connor;
    • Balachandrakumar, Vinay;
    • Kassab, Mohamed;
    • Devonport, Joshua;
    • Matthews, Charmaine;
    • Fox, James;
    • Baggus, Elisabeth;
    • Henney, Alexander;
    • Stern, Nicholas;
    • Cuthbertson, Daniel J;
    • Palmer, Daniel;
    • Johnson, Philip J;
    • Hughes, David M;
    • Hydes, Theresa J;
    • Cross, Timothy J S
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Circulating pancreatic polypeptide concentrations predict visceral and liver fat content.

    Published in:
    2015
    By:
    • Sam, Amir H;
    • Sleeth, Michelle L;
    • Thomas, E Louise;
    • Ismail, Nurhafzan A;
    • Mat Daud, Norlida;
    • Chambers, Edward;
    • Shojaee-Moradie, Fariba;
    • Umpleby, Margot;
    • Goldstone, Anthony P;
    • Le Roux, Carel W;
    • Bech, Paul;
    • Busbridge, Mark;
    • Laurie, Rosemary;
    • Cuthbertson, Daniel J;
    • Buckley, Adam;
    • Ghatei, Mohammad A;
    • Bloom, Stephen R;
    • Frost, Gary S;
    • Bell, Jimmy D;
    • Murphy, Kevin G
    Publication type:
    journal article
    46
    47

    Short-term decreased physical activity with increased sedentary behaviour causes metabolic derangements and altered body composition: effects in individuals with and without a first-degree relative with type 2 diabetes.

    Published in:
    Diabetologia, 2018, v. 61, n. 6, p. 1282, doi. 10.1007/s00125-018-4603-5
    By:
    • Bowden Davies, Kelly A.;
    • Sprung, Victoria S.;
    • Norman, Juliette A.;
    • Thompson, Andrew;
    • Mitchell, Katie L.;
    • Halford, Jason C. G.;
    • Harrold, Jo A.;
    • Wilding, John P. H.;
    • Kemp, Graham J.;
    • Cuthbertson, Daniel J.
    Publication type:
    Article
    48
    49
    50

    The Impact of <sup>68</sup>Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours.

    Published in:
    Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.654975
    By:
    • Cuthbertson, Daniel J.;
    • Barriuso, Jorge;
    • Lamarca, Angela;
    • Manoharan, Prakash;
    • Westwood, Thomas;
    • Jaffa, Matthew;
    • Fenwick, Stephen W.;
    • Nuttall, Christina;
    • Lalloo, Fiona;
    • Prachalias, Andreas;
    • Pizanias, Michail;
    • Wieshmann, Hulya;
    • McNamara, Mairead G.;
    • Hubner, Richard;
    • Srirajaskanthan, Raj;
    • Vivian, Gillian;
    • Ramage, John;
    • Weickert, Martin O.;
    • Pritchard, D Mark;
    • Vinjamuri, Sobhan
    Publication type:
    Article